Urological cancer, Malmö
341 – 350 of 555
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
TCF7L2 type 2 diabetes risk variant, lifestyle factors, and incidence of prostate cancer.
- Contribution to journal › Article
-
Mark
Galiellalactone is a Direct Inhibitor of STAT3 in Prostate Cancer Cells.
- Contribution to journal › Article
-
Mark
Tractable and Reliable Registration of 2D Point Sets
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
The fungal metabolite galiellalactone interferes with the nuclear import of NF-κB and inhibits HIV-1 replication.
- Contribution to journal › Article
-
Mark
Interobserver variability in the pathological assessment of radical prostatectomy specimens: Findings of the Laparoscopic Prostatectomy Robot Open (LAPPRO) study.
- Contribution to journal › Article
-
Mark
Plasma alkylresorcinol metabolites as biomarkers for whole-grain intake and their association with prostate cancer: a Swedish nested case-control study.
- Contribution to journal › Article
-
Mark
Preclinical evaluation of (111)In-DTPA-INCA-X anti-Ku70/Ku80 monoclonal antibody in prostate cancer.
- Contribution to journal › Article
-
Mark
Enzalutamide in metastatic prostate cancer before chemotherapy
- Contribution to journal › Article
- 2013
-
Mark
A Systematic Review of the Volume-Outcome Relationship for Radical Prostatectomy
- Contribution to journal › Scientific review
-
Mark
Copy number variants in the kallikrein gene cluster.
- Contribution to journal › Article
